山西吉林局地多种动物异常 疑祸起转基因玉米

　　美国专利局网站截屏及中英文说明如下：

　　【网站原文】

　　United States Patent 6,897,363

　　Inbred maize line PH4CV

　　Abstract

　　An inbred maize line, designated PH4CV, the plants and seeds of inbred maize line PH4CV, methods for producing a maize plant, either inbred or hybrid, produced by crossing the inbred maize line PH4CV with another maize plant, and hybrid maize seeds and plants produced by crossing the inbred line PH4CV with another maize line or plant and to methods for producing a maize plant containing in its genetic material one or more transgenes and to the transgenic maize plants produced by that method. This invention also relates to inbred maize lines derived from inbred maize line PH4CV, to methods for producing other inbred maize lines derived from inbred maize line PH4CV and to the inbred maize lines derived by the use of those methods.

　　Inventors: Barker; Thomas Charles (York, NE)

　　Assignee: Pioneer Hi-Bred International, Inc. (Johnston, IA)

　　Appl. No.: 10/271,942

　　Filed: October 15, 2002

　　Current U.S. Class: 800/320.1 ;435/412; 800/275; 800/278; 800/279; 800/281; 800/298; 800/300.1; 800/301; 800/302; 800/303

　　Current International Class: A01H 5/10 (20060101); A01H 001/00 (); A01H 004/00 (); A01H 005/00 (); A01H 005/10 (); C12N 015/82 ()

　　Field of Search: 800/320.1,266,275,278,279,284,298,300.1,301,302,303 435/412

　　【中文翻译】专利号为6,897,363

　　PH4CV的“摘要”：(本专利指：)命名为PH4CV的自交系玉米;其植株和种子;为得到该植株而采取的栽培方式，不论(采用的方式)是自交还是杂交——以PH4CV玉米和它种玉米杂交所得杂交玉米种子和植株;自身基因物质中包含一种或多种被转入基因的玉米植株，其培育方法;以及用这种方法培育的转基因玉米的植株。本发明还涉及以PH4CV为源头的自交系玉米;培育另外自交系玉米的的方法，以及培育自交系玉米所用的本方法。

　　发明人：Barker; Thomas Charles (York, NE)

　　受托方：Pioneer Hi-Bred International, Inc. (Johnston, IA)

　　申请专利号：10/271,942

　　申请日期：2002年10月15日

　　现有美国类别：800/320.1 ;435/412; 800/275; 800/278; 800/279; 800/281; 800/298; 800/300.1; 800/301; 800/302; 800/303

　　现有国际类别：A01H 5/10 (20060101); A01H 001/00 (); A01H 004/00 (); A01H 005/00 (); A01H 005/10 (); C12N 015/82 ()

　　类别号专利涉及范围检索区(Fields of Search)： 800/320.1,266,275,278,279,284,298,300.1,301,302,303 435/412

39健康网(www.39.net)专稿，未经书面授权请勿转载。